This late-stage clinical trial company focuses on preventing inflammation and acute organ injury. It is developing a platform of new drugs to prevent inflammation in the kidneys, liver and lungs...

To read the full story on AllPennyStocks.com, click here.

Grafico Azioni Arch Biopartners (TSXV:ARCH)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di Arch Biopartners
Grafico Azioni Arch Biopartners (TSXV:ARCH)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di Arch Biopartners